Top Companies Transforming the Global Colorectal Cancer Screening Market

According to Fortune Business Insights, the global colorectal cancer screening market size was valued at USD 18.62 billion in 2025 and is projected to grow from USD 19.42 billion in 2026 to USD 27.69 billion by 2034, exhibiting a CAGR of 4.50% during the forecast period. North America dominated the colorectal cancer screening market with a market share of 65.04% in 2025.

The growing prevalence of colorectal cancer, increasing awareness of early disease detection, and rising adoption of advanced screening technologies are supporting market expansion. Colorectal cancer screening involves medical tests and diagnostic procedures used to identify precancerous polyps or cancer at an early stage. These screening methods include stool-based tests, colonoscopy, flexible sigmoidoscopy, and advanced molecular diagnostic techniques. Early detection enables timely medical intervention and improves treatment outcomes.

Key Factors Driving the Colorectal Cancer Screening Market Growth

Rising Prevalence of Colorectal Cancer

The increasing incidence of colorectal cancer worldwide is creating a greater need for effective screening solutions. Lifestyle changes, unhealthy dietary habits, physical inactivity, obesity, and an aging population are contributing to the growing disease burden. Consequently, healthcare providers are emphasizing regular screening programs to identify abnormalities and reduce cancer-related mortality.

Growing Awareness of Early Cancer Detection

Increasing awareness of preventive healthcare and early cancer diagnosis is encouraging individuals to undergo routine colorectal cancer screening. Government initiatives, public health campaigns, and recommendations from healthcare organizations are supporting screening participation, particularly among high-risk populations and eligible age groups.

Advancements in Screening and Diagnostic Technologies

Technological developments in molecular diagnostics, genetic testing, and stool-based screening methods are improving colorectal cancer detection. Non-invasive screening options are gaining attention because they offer convenient testing alternatives and may encourage greater participation among individuals who are reluctant to undergo invasive procedures.

Emerging Trends in the Colorectal Cancer Screening Market

Increasing Adoption of Non-Invasive Screening Tests

Non-invasive screening methods, including fecal immunochemical tests (FIT) and stool-based DNA tests, are gaining popularity. These solutions offer convenient sample collection and can help identify potential signs of colorectal cancer without requiring an immediate invasive procedure. Their growing availability is supporting broader screening adoption.

Growing Use of Advanced Molecular Diagnostics

Molecular diagnostic technologies are becoming increasingly important in colorectal cancer screening. These methods analyze genetic and molecular biomarkers to identify cancer-associated changes. Continued research into blood-based and stool-based biomarkers is expected to create opportunities for more accessible screening solutions.

Expansion of Organized Screening Programs

Healthcare authorities and medical institutions are strengthening colorectal cancer screening initiatives to improve early diagnosis rates. Organized screening programs, awareness campaigns, and improved access to diagnostic services are encouraging more individuals to participate in preventive healthcare.

Regional Analysis of the Colorectal Cancer Screening Market

North America dominated the global colorectal cancer screening market with a share of 65.04% in 2025. The region's leadership is supported by advanced healthcare infrastructure, increasing awareness of early cancer detection, established screening guidelines, and the availability of advanced diagnostic technologies.

The presence of leading diagnostic companies, growing adoption of stool-based screening tests, and supportive healthcare reimbursement frameworks are further strengthening the regional market. Additionally, government-backed cancer prevention initiatives and increasing investments in diagnostic research are contributing to market development.

Competitive Landscape of the Colorectal Cancer Screening Market

The global colorectal cancer screening market comprises diagnostic technology developers, medical device manufacturers, biotechnology companies, and healthcare solution providers. Key participants are focusing on product innovation, strategic collaborations, technological advancements, and portfolio expansion to strengthen their market positions.

Major companies operating in the colorectal cancer screening market include:

• NOVIGENIX SA (Switzerland): Focuses on developing molecular diagnostic solutions and biomarker-based technologies for colorectal cancer detection.

• EIKEN CHEMICAL CO., LTD. (Japan): Offers diagnostic products, including fecal immunochemical testing solutions, supporting colorectal cancer screening programs.

• Clinical Genomics Technologies Pty Ltd. (U.S.): Develops molecular diagnostic technologies and biomarker-based solutions for colorectal cancer detection.

• Exact Sciences Corporation (U.S.): Provides non-invasive colorectal cancer screening solutions, including Cologuard, a stool-based DNA screening test.

• Epigenomics AG (Germany): Focuses on molecular diagnostic technologies and blood-based biomarker solutions for colorectal cancer screening.

• bioMérieux, Inc. (France): Develops in vitro diagnostic solutions and technologies supporting clinical disease detection.

• Olympus Corporation (Japan): Provides endoscopic imaging systems and medical technologies used in colorectal cancer detection and diagnosis.

• KARL STORZ SE & Co. KG (Germany): Specializes in endoscopic equipment and visualization technologies used in diagnostic and surgical procedures.

• FUJIFILM Holdings America Corporation (Japan): Offers medical imaging and endoscopic technologies that support colorectal examination and cancer detection.

  
  

Get Free Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/colorectal-cancer-screening-market-101144 

Future Outlook of the Colorectal Cancer Screening Market

The global colorectal cancer screening market is expected to witness steady growth through 2034, supported by increasing cancer awareness, rising demand for early diagnosis, and continuous advancements in screening technologies. The development of non-invasive diagnostic methods, including stool-based and blood-based testing solutions, is expected to improve screening accessibility and patient participation.

Furthermore, investments in molecular diagnostics, biomarker discovery, and advanced endoscopic systems are likely to create new opportunities for market participants. As healthcare systems increasingly prioritize preventive care and early cancer detection, colorectal cancer screening will remain an important component of global cancer prevention strategies.

Explore Japan’s Market Opportunities - Latest - Colorectal Cancer Screening Market - Insights